Page last updated: 2024-08-23

daunorubicin and Autoimmune Demyelinating Disease, Peripheral

daunorubicin has been researched along with Autoimmune Demyelinating Disease, Peripheral in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campos, T; Franco-Macías, E; Gómez-Aranda, F; González Pérez, P; Montes-Latorre, E; Serrano-Pozo, A1
Caballero, MD; Hernández, JM; Rodríguez Vicente, G; Sánchez, C1

Other Studies

2 other study(ies) available for daunorubicin and Autoimmune Demyelinating Disease, Peripheral

ArticleYear
Vincristine-induced acute neurotoxicity versus Guillain-Barré syndrome: a diagnostic dilemma.
    European journal of neurology, 2007, Volume: 14, Issue:7

    Topics: Action Potentials; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dexamethasone; Diagnosis, Differential; Erectile Dysfunction; Fatal Outcome; Guillain-Barre Syndrome; Humans; Hydrocortisone; Male; Methotrexate; Paraparesis; Paresthesia; Polyradiculoneuropathy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Urination Disorders; Vincristine

2007
[Guillain-Barr+e syndrome after autologous bone marrow transplantation].
    Sangre, 1998, Volume: 43, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Fatal Outcome; Humans; Leukemia, Monocytic, Acute; Lymphocyte Subsets; Middle Aged; Polyradiculoneuropathy; Transplantation, Autologous

1998